Reaction Details Report a problem with these data
Target
Epidermal growth factor receptor [696-1022,L858R]
Ligand
BDBM554465
Substrate
n/a
Meas. Tech.
Kinase Hotspot Assay
IC50
5.41±n/a nM
Citation
 Mahmoud, GE; Choi, HS; Yoo, KH; Han, DK; Oh, CH; Mohammed, A; Mohammed, IE; Ammar, UM Imidazooxazole derivative having antitumor effect, and pharmaceutical composition including same US Patent  US11332479 Publication Date 5/17/2022 
Target
Name:
Epidermal growth factor receptor [696-1022,L858R]
Synonyms:
EGF-R Tyrosine Kinase Mutant (L858R) | EGFR | EGFR_HUMAN | ERBB | ERBB1 | Epidermal growth factor receptor [696-1022,L858R] | HER1 | c-raf
Type:
Tyrosine-protein kinase
Mol. Mass.:
37296.75
Organism:
Homo sapiens (Human)
Description:
P00533[696-1022,L858R]
Residue:
327
Sequence:
GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG
  
Inhibitor
Name:
BDBM554465
Synonyms:
US11332479, Compound 52III
Type:
Small organic molecule
Emp. Form.:
C24H21F2N7O2S2
Mol. Mass.:
541.596
SMILES:
Nc1cc(ccc1F)-c1nc2sccn2c1-c1ccnc(NCCCNS(=O)(=O)c2ccc(F)cc2)n1
Structure:
Search PDB for entries with ligand similarity: